"I" . . . "Current opinion on aspirin in primary prevention of atherosclerotic cardiovascular diseases. Is there any difference between diabetic and non-diabetic patients?"@en . "0010-8650" . "67533" . "type2diabetes; primary prevention; cardiovasculardisease; Aspirin"@en . "Current opinion on aspirin in primary prevention of atherosclerotic cardiovascular diseases. Is there any difference between diabetic and non-diabetic patients?" . "6"^^ . "Rosolov\u00E1, Hana" . "Nussbaumerov\u00E1, Barbora" . . "RIV/00216208:11140/13:10134202" . "Cor et Vasa" . "[1BD66C3AB2AD]" . "2" . "Current opinion on aspirin in primary prevention of atherosclerotic cardiovascular diseases. Is there any difference between diabetic and non-diabetic patients?"@en . "2"^^ . . "RIV/00216208:11140/13:10134202!RIV14-MSM-11140___" . . . "2"^^ . "Aspirin reduces vasculardeath by approximately 15% and nonfatal vascular events by about 30% in secondary prevention. The evidence in primary prevention in non-diabetic subjects is not so powerful. The benefit of aspirin primary prevention in type 2 diabetes remains to be advocated definitely." . "CZ - \u010Cesk\u00E1 republika" . . "Aspirin reduces vasculardeath by approximately 15% and nonfatal vascular events by about 30% in secondary prevention. The evidence in primary prevention in non-diabetic subjects is not so powerful. The benefit of aspirin primary prevention in type 2 diabetes remains to be advocated definitely."@en . . . . . . "11140" . . "10.1016/j.crvasa.2012.11.019" . . "55" . . "Current opinion on aspirin in primary prevention of atherosclerotic cardiovascular diseases. Is there any difference between diabetic and non-diabetic patients?" . . "http://download.journals.elsevierhealth.com/pdfs/journals/0010-8650/PIIS0010865012001373.pdf" . .